[posting]57836387[/posting]This blog post is for my followers in advance of an upcoming article submission here on Seeking Alpha.
Geron has major upcoming catalysts, I list them below with my price targets:
- EHAC '18 Late Breaking Abstracts Available Online (June 1) - $6
- European Hematology Association Congress (June 14-17) - $8
- Accelerated Approval In Myelofibrosis (July 31) - $16
- Continuation Decision by Johnson and Johnson (JNJ) (August 31) - $20
- Accelerated Approval in Myelodysplastic Syndrome (September 30) - $30
https://seekingalpha.com/instablog/3163201-medtechbio/516481…" target="_blank" rel="nofollow ugc noopener">
https://seekingalpha.com/instablog/3163201-medtechbio/516481…
Wenn diese spekulativen Prognosen inkl. Kursvorhersagen wirklich so eintreffen würden, dann denke ich, wären wir als Geron-Aktionäre doch mehr als zufrieden, oder ??
Time will tell
Let`s hope the best